(Q40515045)

21 September 2017

title

Treatment of rapidly growing K-BALB and CT26 mouse tumours using Semliki Forest virus and its derived vector (English)

1 reference

21 September 2017

0 references

0 references

Smyth JW

1

1 reference

21 September 2017

Fleeton MN

series ordinal

2

1 reference

21 September 2017

Sheahan BJ

series ordinal

3

1 reference

21 September 2017

Atkins GJ

series ordinal

4

1 reference

21 September 2017

publication date

1 January 2005

1 reference

21 September 2017

1 reference

21 September 2017

volume

12

1 reference

21 September 2017

issue

2

1 reference

21 September 2017

page(s)

147-159

1 reference

Immunogenicity and vaccine efficacy of synthetic peptides containing Semliki Forest virus B and T cell epitopes

21 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

The molecular pathogenesis of Semliki Forest virus: a model virus made useful?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Semliki Forest virus vectors for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Alphavirus vectors as tools in cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Semliki Forest virus-based vaccines: persistence, distribution and pathological analysis in two animal systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Recombinant Semliki Forest virus particles expressing louping ill virus antigens induce a better protective response than plasmid-based DNA vaccines or an inactivated whole particle vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Effect of intranasal administration of Semliki Forest virus recombinant particles expressing reporter and cytokine genes on the progression of experimental autoimmune encephalomyelitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Death mechanisms in cultured cells infected by Semliki Forest virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

The Semliki Forest virus vector induces p53-independent apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Inhibition of human lung carcinoma cell growth by apoptosis induction using Semliki Forest virus recombinant particles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Induction of apoptosis in BCL-2-expressing rat prostate cancer cells using the Semliki Forest virus vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Immunotherapy with recombinant SFV-replicons expressing the P815A tumor antigen or IL-12 induces tumor regression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Replication-defective recombinant Semliki Forest virus encoding GM-CSF as a vector system for rapid and facile generation of autologous human tumor cell vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Transfer of the murine interleukin-12 gene in vivo by a Semliki Forest virus vector induces B16 tumor regression through inhibition of tumor blood vessel formation monitored by Doppler ultrasonography

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Eradication of established HPV16-transformed tumours after immunisation with recombinant Semliki Forest virus expressing a fusion protein of E6 and E7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Cytolytic viruses as potential anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Herpes simplex virus as an in situ cancer vaccine for the induction of specific anti-tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Blocking oncogenic Ras signaling for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Characterization of murine sarcoma virus (Kirsten) transformation of mouse and human cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Antigenic properties of murine sarcoma virus-transformed BALB-3T3 nonproducer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Alphaviruses induce apoptosis in Bcl-2-overexpressing cells: evidence for a caspase-mediated, proteolytic inactivation of Bcl-2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Cytokines in cancer pathogenesis and cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Cancer vaccines: between the idea and the reality

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

In vivo antitumor activity of Sindbis viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Systemic tumor targeting and killing by Sindbis viral vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

Two-helper RNA system for production of recombinant Semliki forest virus particles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

7 January 2021

The nucleocapsid-binding spike subunit E2 of Semliki Forest virus requires complex formation with the E1 subunit for activity.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

7 January 2021

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

1 reference

7 January 2021

Codon 12 and codon 13 mutations at the K-ras gene induce different soft tissue sarcoma types in nude mice

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

7 January 2021

bcl-2 acts early to restrict Semliki Forest virus replication and delays virus-induced programmed cell death

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

7 January 2021

Immuno-viral therapy as a new approach for the treatment of brain tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3302390

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3302390

1 reference

Dimensions Publication ID

21 September 2017

1015665826

0 references

1 reference